Pharmaceutical Manufacturing: Liquid Dosage Forms, Suspensions, Emulsions, Tablets, and Capsules

Overview and Stability Factors of Liquid Dosage Forms

Liquid dosage forms present distinct physiological and therapeutic advantages compared to solid oral dosage forms. The primary advantages include ease of administration for patients who experience difficulty swallowing tablets or capsules, as well as immediate availability for absorption of the medicinal substance. Because the drug is already in solution or finely dispersed, it is absorbed more rapidly and efficiently than solid counterparts.

Conversely, liquid formulations present several significant technical disadvantages. These include chemical and physical instability of certain drug molecules in liquid media, the need for specialized solubilization techniques for poorly soluble active pharmaceutical ingredients, and the mandatory requirement for pharmaceutical elegance with respect to taste, appearance, and viscosity.

Drug degradation and instability in liquid systems are driven by five principal environmental and chemical conditions:

1. pH Influence: Degradation is frequently catalyzed by the actions of hydrogen ions ($H^+$) and hydroxyl ions ($OH^-$). Establishing the optimum pH for maximum chemical stability is critical during formulation development, and appropriate buffer systems are routinely employed to maintain a constant pH throughout the product shelf life.

2. Temperature: The rate of drug degradation increases as temperature rises. Accelerated stability studies are conducted during product development to establish proper storage conditions, such as requirements for storage in a cool place or refrigeration.

3. Concentration of Reactants: Stability studies must evaluate the exact quantitative loss or degradation of the active drug over specified time periods relative to its initial concentration.

4. Light or Radiation: Photolytic degradation occurs in complex chemical structures exposed to light energy. The rate of degradation is influenced by the intensity and wavelength of light, as well as container geometry and surface area. Amber glass containers, which transmit light only above $470\text{ m}\frac{1}{\text{u}}$ (or $nm$), provide superior photoprotection compared to flint glass containers, which transmit light above $300\text{ m}\frac{1}{\text{u}}$.

5. Packaging Components: Inadequate or faulty container-closure systems can compromise even the most stable chemical formulation. Container selection must ensure adequate barrier protection during extended storage under adverse or fluctuating environmental conditions.

Formulation Considerations and Pharmaceutical Elegance in Liquids

Formulating poorly soluble drug substances requires specific physicochemical techniques to achieve adequate solution concentration and chemical stability:

• Co-solvency: Non-polar molecules and weak electrolytes frequently exhibit poor solubility in water. Solubility can be enhanced by incorporating a water-miscible organic solvent in which the drug is highly soluble. The added solvents are designated as co-solvents. Examples include colorants that are soluble in alcohol but insoluble in water, and phenobarbital, which demonstrates significantly higher solubility in alcohol than in water.

• pH Control: A substantial proportion of modern chemotherapeutic agents function as weak acids or weak bases, making their aqueous solubility highly dependent on the pH of the medium.

• Solubilisation: Defined by McBain as the spontaneous passage of a poorly water-soluble solute into an aqueous solution of a soap or detergent, forming a thermodynamically stable solution. Surfactants added at low concentrations orient at the air-liquid interface. As surfactant concentration increases, the interface becomes saturated, forcing excess surfactant molecules into the bulk liquid phase. At higher concentrations, these molecules form organized colloidal aggregates known as micelles. Solubilization occurs when solute molecules dissolve within or adsorb onto the micelles. Polyoxyethylene sorbitan fatty acid esters (tweens) are common examples of solubilizing surfactants.

• Complexation: Organic compounds in solution associate intermolecularly. Adding a specific complexing agent forms a soluble molecular complex. Examples include combinations of nicotinamide and cyclodextrin.

• Hydrotrophy: Hydrotrophy refers to the enhanced aqueous solubility of a solute induced by high concentrations of specific non-surfactant additives. Hydrotrophic solutions do not exhibit colloidal properties, and the precise solubilization mechanism involves solute dissolution into oriented molecular clusters.

• Chemical Modification of Drugs: Poorly soluble drugs can be chemically converted into water-soluble derivatives. For example, betamethasone alcohol exhibits a water solubility of only $5.8\text{ mg/100 mL}$, whereas its ester derivative, betamethasone disodium phosphate, possesses a water solubility of $10\text{ g/100 mL}$. While effective, chemical modification requires rigorous evaluation regarding potential impacts on therapeutic biological activity and systemic toxicity.

Pharmaceutical elegance requires unpalatable active ingredients to be formulated into visually appealing and pleasant-tasting preparations:

• Flavoring: Flavor selection relies on empirical trial-and-error evaluation by formulators. Evaluation is performed by a tasting panel of approximately 3 individuals who evaluate flavor samples sequentially from lowest dilution to higher concentrations. Monosodium glutamate is utilized in food systems but is excluded from pharmaceutical preparations.

• Appearance and Clarity: Product color must align logically with the added flavor (e.g., strawberry flavor paired with red color; lemon flavor paired with yellow color). Solution clarity is achieved via filtration through sintered glass after passing through layers of filter pads or filter aids.

• Preservatives: Antimicrobial preservatives prevent bacterial and fungal proliferation, which cause product degradation and present health risks to patients. An ideal preservative must display broad-spectrum antimicrobial activity, maintain physical, chemical, and microbiological stability throughout the shelf life, and remain non-toxic, non-sensitizing, adequately soluble, compatible, and organoleptically acceptable at target concentrations.

Preservatives are classified into four structural groups:

1. Acidic Preservatives: Includes alkyl esters of p-hydroxybenzoic acid, benzoic acid, and benzoate salts. Boric acid and phenols are restricted to external formulations.
2. Neutral Preservatives: Includes chlorobutanol, benzyl alcohol, and phenylethyl alcohol for internal preparations.
3. Mercurial Preservatives: Includes thimerosal, phenylmercuric acetate, and phenylmercuric nitrate for external use.
4. Quaternary Ammonium Compounds: Includes benzalkonium chloride and cetylpyridinium chloride.

Esters of p-hydroxybenzoic acid (parabens) are widely used due to their chemical stability, neutral pH, non-toxic, non-irritating, and non-allergenic profile, and dual antibacterial and antifungal activity. Combinations of methylparaben and propylparaben are routinely used. Neutral, mercurial, and quaternary ammonium preservatives are utilized in ophthalmic, nasal, and parenteral dosage forms, but are omitted from oral liquid formulations.

• Sweetening Agents: Sweeteners represent a major proportion of total dissolved solids in oral liquids:

  • Sucrose: Widely utilized due to high purity, reasonable cost, and chemical/physical stability across pH $4$ to $8$. It can be combined with polyols to prevent sugar crystallization. A major disadvantage is cap-locking, which occurs when sucrose crystallizes on the container thread and interferes with bottle opening.
  • Liquid Glucose: An extremely viscous liquid prepared by partial acid hydrolysis of starch, consisting primarily of dextrose along with dextrin and maltose. It imparts both body and sweetness to liquid formulations.
  • Artificial Sweeteners: Sodium and calcium salts of saccharin are soluble in water, alcohol, and polyols, remaining stable across pH $3$ to $8$. Cyclamates are $15\times$ to $30\times$ sweeter than sucrose, whereas saccharin is $250\times$ to $500\times$ sweeter than sucrose. To eliminate the bitter aftertaste of saccharin, a blend of $20\text{ parts}$ cyclamate to $2\text{ parts}$ saccharin is formulated at a concentration of $1\text{\% w/v}$.

• Viscosity Control: High viscosity can impede liquid dilution by gastrointestinal fluids, delaying drug release and absorption. High concentrations of carboxymethylcellulose (CMC) require incorporation of trivalent or divalent cations such as $Al^{3+}$, $Fe^{3+}$, or $Ca^{2+}$. Viscosity-modifying agents include polyvinylpyrrolidone (PVP), methylcellulose, and sodium carboxymethylcellulose (sodium CMC).

Manufacturing Equipment, Filtration, and Packaging of Liquids

The physical principles governing homogeneous liquid preparation are independent of batch scale. The solubility of the solute and the intermolecular interactions at thermodynamic equilibrium remain constant regardless of compounding methodology, provided volatile components are not lost during heating steps. The rate at which equilibrium is achieved depends on equipment configuration, processing parameters, and packaging procedures.

Manufacturing equipment for oral solutions includes:

• Mixing Tanks: Constructed of polished stainless steel, equipped with agitators, jacketed for heating and cooling, fully covered, and outfitted with see-through charging ports and internal illumination. Following compounding, liquids undergo clarification via filtration into adjacent storage tanks prior to release by Quality Control.
• Transfer Systems: Released bulk liquids are transferred via portable transport tanks, positive displacement pumping, or gravity feed lines.
• Measuring Devices: Volumetric cylinders, pipettes, and gravimetric balances. Gravimetric measurement is preferred over volumetric measurement in large-scale manufacturing due to enhanced accuracy.

Filtration is a unit operation in which a liquid-solid slurry is forced through a porous medium, depositing solids as a cake on the filter medium while discharging clear filtrate. Filter media are classified as follows:

• Filter Cloth: Woven from natural fibers, synthetic fibers, or metallic wire (e.g., stainless steel wire cloth, cotton, nylon). Used for straining syrups. Nylon is preferred because it is resistant to molds, fungi, and bacteria, non-absorptive, and autoclavable.
• Non-woven Media:
  • Felt: Mechanically interlocked fibrous mass free of bonding agents, offering controlled pore sizes for gelatinous solutions or fine particulate removal (e.g., asbestos pads).
  • Bonded Fabric: Manufactured by binding textile fibers with resins, solvents, and plasticizers; usage is limited due to potential additive leaching or interaction.
  • Kraft Paper: A pharmaceutical standard offering controlled porosity, low absorption capacity, and low cost. Plate and frame filter presses represent the simplest and most widely used commercial pressure filter configuration.
• Membrane Filters: Thin polymeric membranes (approximately $150\text{ }\frac{1}{\text{u}}\text{m}$ thick) containing millions of uniform pores ranging from $0.05\text{ }\frac{1}{\text{u}}\text{m}$ to $14\text{ }\frac{1}{\text{u}}\text{m}$. Constructed from cellulose esters, nylon, Teflon, polyvinyl chloride (PVC), or silver, and used in microfiltration and sterile solution processing.
• Filter Aids: Insoluble, highly porous, non-compressible particulate materials added to slurries to form a protective cake that screens solids without clogging the primary medium. Diatomite (diatomaceous earth, infusorial earth, kieselguhr, celite, super gel) consists primarily of inert silica. Cellulose and asbestos have limited application due to cost, whereas activated carbons pose cleanliness issues. Filter aids are typically added at concentrations not exceeding $0.05\text{\%}$. Because flow rate is inversely proportional to viscosity, heating heavy syrups reduces viscosity and increases filtration flow rate.

Compounding procedures require pre-dissolving low-concentration solutes, such as dyes, prior to addition to the main batch volume. Formulas express liquid components in both volumetric and weight units to facilitate gravimetric processing.

Packaging filling operations utilize three principal filling methods:

1. Gravimetric Filling: Limited to very large containers or highly viscous preparations.
2. Volumetric Filling: Pumping liquid at constant pressure through a calibrated orifice for a fixed time duration. Container dimensional variations lead to variable fill heights despite accurate volume delivery.
3. Constant-Level Filling: Uses the container itself to regulate fill volume by filling to a fixed height. Dimensional variations in container capacity lead to variations in net fill volume. High-speed liquid filling operations require active foam mitigation.

Drug product labeling encompasses container labels, package inserts, brochures, booklets, price lists, bulletins, slides, and promotional literature. Legend (prescription) drug labels must include:

• Non-proprietary (generic) name and trademark/brand name.
• Name and address of the manufacturer or distributor.
• Quantitative statement of drug content per unit weight, volume, or dosage unit.
• Pharmaceutical dosage form and net container contents.
• Prescription legend: "Caution: Federal Law prohibits dispensing without prescription" (or equivalent).
• Recommended dosage and pediatric guidelines.
• Reference to the package insert.
• Special storage instructions, FDA drug registration number, lot/batch control number, expiration date, Rx symbol, and habit-forming warnings where applicable.

Over-the-Counter (OTC) drug labeling omits the Rx symbol and prescription legend, but must state the pharmacological category, intended indications, quantitative dosing per age group/condition, administration frequency and timing, max duration before consulting a physician, route of administration, preparation instructions (e.g., shaking, dilution), and explicit warnings against misuse.

Products lacking explicit storage parameters must be protected from moisture, freezing, and excessive heat.

Theoretical and Practical Aspects of Pharmaceutical Suspensions

Pharmaceutical suspensions are heterogeneous, two-phase systems comprising an insoluble particulate internal (dispersed) phase uniformly distributed throughout a liquid or semisolid continuous (external) phase. Suspensions include lotions, gels, magmas, milks, and mixtures. Because solids settle over time, formulations must minimize sedimentation velocity and facilitate rapid redispersibility upon mild agitation.

Wetting behavior is governed by the contact angle between the liquid phase and the solid surface. Hydrophilic solids display strong liquid affinity, are easily wetted by water, and increase aqueous phase viscosity. Hydrophobic solids repel water, entrap air pockets, float on the surface, and require wetting agents. Wetting properties are modified using:

• Surfactants that lower solid-liquid interfacial tension by adsorbing hydrophobic tails onto solid surfaces while extending polar heads into the aqueous phase.
• Hydrophilic polymers and insoluble clays, such as sodium carboxymethylcellulose, bentonite (hydrated aluminum silicate clay), veegum (aluminum magnesium silicate), and colloidal silica. These agents build viscosity and can induce thixotropy (formation of a gel-like structure that liquefies upon shaking).

Interparticle interaction is governed by lyophobic (non-wetting, electrolyte-sensitive) and lyophilic (wetting, electrolyte-insensitive) behaviors. Lyophilic polymers can undergo salting out at high salt concentrations. Under the Schultze-Hardy rule, the coagulating power of an electrolyte increases with the valence of the counter-ion. Optimal flocculation concentrations are:

• Monovalent ions: $25\text{ mmoles/L}$ to $150\text{ mmoles/L}$
• Divalent ions: $0.5\text{ mmoles/L}$ to $2.0\text{ mmoles/L}$
• Trivalent ions: $0.01\text{ mmoles/L}$ to $0.1\text{ mmoles/L}$

Suspension systems are categorized into two physical states:

• Flocculated Systems: Particles aggregate into loose, fibrous clusters (flocs). They settle rapidly to form a porous, high-volume sediment that does not form a hard cake, leaving a clear supernatant. Flocculated systems are colloidally unstable but easily redispersed by mild shaking.
• Deflocculated Systems: Particles exist as individual entities. They settle slowly, but eventually form a dense, compact, strongly bonded sediment (hard cake) that is extremely difficult to redisperse. Deflocculated systems represent colloidally stable (peptized) states but produce pharmaceutically unacceptable suspensions over time.

Sedimentation velocity is governed by Stokes' law, where settling velocity is directly proportional to particle size squared and density difference, and inversely proportional to vehicle viscosity.

Preparation methods include:

1. Dispersion Method: Powdered solids are pulverized via micronization (fluid energy milling using turbulent air streams to produce particle sizes $≤ 5\text{ }\frac{1}{\text{u}}\text{m}$) or spray drying, followed by dispersion in a vehicle containing wetting agents.
2. Organic Solvent Precipitation: Water-insoluble drugs are dissolved in a water-miscible organic solvent (e.g., ethanol, methanol, propylene glycol, polyethylene glycol, acetone) and poured into distilled water under controlled agitation. Prednisolone dissolved in acetone yields the desired crystal habit, whereas aqueous methanol yields an un-suspendable crystal form. Parenteral and inhalation suspensions require particle sizes ranging from $1\text{ }\frac{1}{\text{u}}\text{m}$ to $5\text{ }\frac{1}{\text{u}}\text{m}$.
3. pH-Induced Precipitation: Applied when drug solubility depends on pH. Estradiol is dissolved in sodium or potassium hydroxide and precipitated as fine particles by adding the solution to acidic media containing hydrochloric, citric, or acetic acid. Insulin precipitates with protamine at its isoelectric point (pH $6.9$ to $7.3$), where net molecular charge is zero.
4. Double Decomposition: Chemical reaction between soluble salts. For example, White Lotion USP is prepared by reacting zinc sulfate with sulfurated potash to form insoluble zinc polysulfide.

Formulation adjuvants include protective colloids (e.g., silica gel up to $10\text{\%}$, aluminum hydroxide gel), suspending agents (synthetic polyacrylic acid/carbopol, modified cellulosics like Methocel HG, proteins like gelatin, clays), preservatives, colorants, and flavorants. Glass packaging uses non-lead soda-lime silica glass (flint glass). Multiple-dose parenteral vials containing steroid or penicillin-dihydrostreptomycin suspensions are internal surface silicone-coated to prevent particle adherence and ensure accurate drainage. Disadvantages of plastic containers include permeability to atmospheric gases, flavor/perfume loss, preservative absorption, and leaching of plasticizers.

Formulation, Manufacture, and Stability of Pharmaceutical Emulsions

An emulsion is a two-phase heterogeneous system consisting of two immiscible liquids, where one liquid (internal/dispersed phase) is dispersed as fine droplets throughout the other (external/continuous phase). Droplet diameters typically range from $1\text{ }\frac{1}{\text{u}}\text{m}$ to $100\text{ }\frac{1}{\text{u}}\text{m}$; droplets below $0.1\text{ }\frac{1}{\text{u}}\text{m}$ exhibit microemulsion/colloidal behavior. Emulsion types include oil-in-water (O/W) and water-in-oil (W/O). O/W emulsions are used for oral, parenteral, and topical administration, whereas W/O emulsions are primarily restricted to topical applications and intramuscular depot injections.

Emulsification requires simultaneous droplet formation, interfacial film formation, and control of droplet aggregation. High interfacial tension between immiscible phases causes rapid droplet coalescence. Monomolecular interfacial films formed by surfactants create physical and electrostatic energy barriers. Alkali soaps (sodium or potassium soaps) promote O/W emulsions, whereas polyvalent soaps (calcium or magnesium soaps) promote W/O emulsions due to non-dissociated hydrocarbon structures.

Continuous phase viscosity influences droplet movement rates during processing; viscometry is evaluated using instruments like the Brookfield viscometer.

Emulsion instability manifests through four physical processes:

• Coalescence: Irreversible fusion of dispersed droplets into larger drops, caused by complete absence or degradation of the interfacial film barrier.
• Flocculation: Reversible clustering of droplets without loss of individual film integrity. The degree of attraction depends on emulsifier chemistry, phase volume ratio, and ionic strength. For example, a $2\text{\%}$ hexadecane-in-water emulsion stabilized with $0.09\text{\%}$ Aerosol O.T. (dioctyl sodium sulfosuccinate, dissolved at $15\text{ g/L}$) remains deflocculated due to electrostatic repulsion. Increasing internal phase volume promotes flocculation; acacia forms flocculated emulsions even at orange oil concentrations as low as $0.002\text{\%}$.
• Creaming: Upward movement of dispersed droplets less dense than the continuous phase.
• Sedimentation: Downward settling of dispersed droplets denser than the continuous phase. Creaming and sedimentation are reversible upon agitation.

Formulation factors include:

• Oil Phase Selection: Restricted to mineral oil, vegetable oils (corn, peanut, sesame, olive), petrolatum, lanolin, beeswax, spermaceti, and long-chain fatty acids/alcohols. Vegetable oils are susceptible to oxidative rancidity.
• Phase Volume Ratio: For liquid emulsions, an internal phase volume of $40\text{\%}$ to $60\text{\%}$ provides maximum physical stability. High internal phase volumes increase viscosity and risk phase inversion.
• Emulsifier Selection: Emulsifiers are classified as:
  1. Natural Agents: Vegetable sources (acacia, tragacanth, pectin, starch) build water-phase viscosity as hydrophilic colloids; animal sources include gelatin, egg yolk, casein, wool fat, and cholesterol.
  2. Finely Divided Solids: Polar inorganic clays (bentonite, veegum) and metallic hydroxides ($Mg(OH)_2$, $Al(OH)_3$, magnesium trisilicate) form particulate barriers at the interface.
  3. Synthetic Surfactants: Anionic (sodium lauryl sulfate), cationic (benzalkonium chloride), non-ionic (polyethylene glycol 400 monostearate, sorbitan esters/Spans, polysorbates/Tweens).

The Hydrophile-Lipophile Balance (HLB) system assigns numerical values (0 to 20) based on molecular polarity. For non-ionic surfactants, the HLB is calculated as:

HLB = \n\frac{\text{weight \% of hydrophilic group}}{5}

Surfactants with HLB values of $3$ to $10$ produce W/O emulsions, whereas HLB values of $8$ to $18$ produce O/W emulsions. Combining sorbitan monostearate (HLB $4.7$) and polyoxyethylene sorbitan monostearate (HLB $14.9$) yields an intermediate HLB of $9.8$, forming a stable, condensed interfacial film.

Viscosity and consistency of topical creams and lotions are enhanced by incorporating long-chain wax components into the oil phase, such as cetyl alcohol, stearyl alcohol, beeswax, and spermaceti. Preservatives (parabens, benzoic acid, quaternary ammonium compounds) must remain in the aqueous phase to maintain antimicrobial efficacy. Lipophilic antioxidants (BHA, BHT, tocopherol, alkyl gallates) or water-soluble antioxidants (gallic acid, citric acid, lecithin) prevent rancidity. Foam generation during high-shear agitation is controlled using defoaming agents, such as cetyl alcohol or dimethylpolysiloxane (Antifoam A).

Manufacturing equipment includes:

• Mechanical Stirrers: Shaft-mounted impellers for low-shear mixing.
• Homogenizers: Pumping liquid under high pressure ($500\text{ psi}$ to $1000\text{ psi}$) through a restricted spring-loaded valve orifice.
• Colloid Mills: High-shear processing using a rotor revolving at $1000\text{ rpm}$ to $20000\text{ rpm}$ with a stator clearance of $0.001\text{ inches}$ to $0.005\text{ inches}$.
• Ultrasonifiers: High-frequency sound waves for low-viscosity systems.

Accelerated stability testing involving thermal cycling ($60^\circ\text{C}$ storage for several weeks followed by refrigeration) correlates with a 2-year ambient shelf life.

Pharmaceutical Tablets: Classification, Formulation, and Processing

Tablets are solid dosage forms containing active drug substances with or without excipients, prepared by compression or molding techniques. Advantages include precise unit dosing, low manufacturing cost, compact packaging, high physical/chemical stability, ease of swallowing, and customizable release profiles. Disadvantages include compression resistance of amorphous or low-density materials, bioavailabilty challenges with poorly wetted drugs, and the requirement to coat objectionable tastes or odors.

Tablets are classified by administration route and functionality:

1. Chewable Tablets: Disintegrated manually in the mouth prior to swallowing. Formulated with a mannitol base, which provides a sweet taste and a cooling oral sensation due to its negative heat of solution ($-28.9\text{ cal/g}$ at $25^\circ\text{C}$). A representative antacid chewable formula comprises:

   • Calcium carbonate: $600\text{ mg}$
   • Mannitol: $502.8\text{ mg}$
   • Confectioners' sugar: $60\text{ mg}$
   • Methocel 15 cps: $18\text{ mg}$
   • Saccharin Sodium: $3.6\text{ mg}$
   • Magnesium Stearate: $12.0\text{ mg}$
   • Total Weight: $1200\text{ mg}$ ($1.2\text{ g}$)

2. Sublingual and Buccal Tablets: Placed beneath the tongue (sublingual) or between the cheek and gum (buccal) for direct mucosal absorption, bypassing first-pass hepatic metabolism and GI degradation.

3. Implantation Tablets (Pellets): Small, sterile compressed units containing pure drug without excipients, surgically implanted subcutaneously to provide prolonged systemic absorption (e.g., testosterone, stilbestrol).

4. Vaginal Tablets (Inserts): Uncoated, bullet- or ovoid-shaped tablets designed for localized vaginal release.

5. Special Oral (Multi-layered) Tablets: Multiple compressed layers prepared by sequential feeding of distinct granulations into single die cavities, isolating incompatible drugs or providing multi-stage release.

6. Compression-Coated Tablets: Core tablet surrounded by an outer compressed dry granulation layer, avoiding liquid-based coating risks. The dry coating typically doubles the core weight and increases tablet diameter by $3/32\text{ inches}$.

7. Effervescent Tablets: Prepared by reacting organic acids (citric acid, tartaric acid) with sodium bicarbonate in the presence of water to release carbon dioxide. Wet fusion involves moistening acids to initiate partial reaction, kneading, granulating, tableting while damp (citric acid acts as a lubricant), and oven drying at $75^\circ\text{C}$. Dry heat fusion blends powders containing $15\text{\%}$ to $25\text{\%}$ citric acid monohydrate and heats the mixture until bound water is liberated to act as the granulating liquid.

8. Soluble Tablets: Molded tablet triturates prepared from moist powder blends using alcohol-water mixtures.

9. Sustained Release Tablets: Deliver an initial therapeutic dose followed by continuous drug release over an $8$ to $12\text{ hour}$ window. Mechanisms include:

   • Coated Beads/Microencapsulation: Drug coated onto inert sugar/starch seeds (e.g., Spansules, Modules, Tempules, Sequels, Measurin).
   • Eroding Matrix: Drug blended with lipids or cellulosic polymers that erode in digestive fluids.
   • Inert Plastic Matrix: Drug leached from compressed matrices of polyethylene, polyvinyl acetate, or polymethacrylate.
   • Chemical Complexes: Slowly dissolving drug complexes (e.g., Dramond).
   • Ion-Exchange Resins: Cationic drug bound to resin complexes.

Compression presses operate as single-punch presses or multi-station rotary presses containing hoppers, feed frames, dies, upper/lower punches, cams, and pressure rolls. Granulations require fluidity (flowability) and compressibility (ability to form a compact mass). Particles should be spherical with a normal size distribution (coarse particles, medium particles, and fines to fill inter-particulate voids).

Excipients are classified by function:

• Diluents (Bulking Agents):
  • Lactose USP: Inexpensive, water-soluble, non-hygroscopic, stable.
  • Starch: Corn, wheat, rice, or potato starch containing $12\text{\%}$ to $14\text{\%}$ bound water.
  • Sucrose: Imparts binding and sweetness; highly hygroscopic.
  • Mannitol: Non-hygroscopic, expensive sweetener for chewables.
  • Avicel: Microcrystalline cellulose; direct compression binder/diluent.
  • Celutab: Hydrolyzed starch containing $95\text{\%}$ to $96\text{\%}$ dextrose and $4.5\text{\%}$ polysaccharides.
• Binders (Adhesives): Form granules from loose powders (e.g., starch paste, gelatin, methylcellulose).
• Disintegrants: Promote tablet breakup in aqueous media by overcoming binder cohesion (e.g., starch, croscarmellose, sodium starch glycolate).
• Lubricants, Glidants, and Anti-adherents: Reduce die wall friction, prevent punch face sticking, and enhance powder flow (e.g., magnesium stearate, talc, stearic acid).
• Colorants and Flavorants: FD&C dyes, D&C dyes, insoluble aluminum lakes (dye adsorbed onto $Al(OH)_3$; maximum concentration rule-of-thumb is $0.03\text{\%}$ soluble dye). Flavors are added dry via spray-dried beadlets to prevent heat volatilization.

Processing methods include:

1. Direct Compression: Compacting crystalline salts (NaCl, KCl) or drugs blended with directly compressible vehicles (spray-dried lactose, Avicel, dicalcium phosphate).
2. Granulation by Compression (Dry Granulation): Used for moisture- or heat-sensitive materials. Powder is compacted into slugs using heavy-duty tablet presses or compressed into continuous ribbons using a Chilsonator (hydraulic rollers), followed by milling and screening.
3. Wet Granulation: Involves comminution, dry blending, binder solution addition, wet screening, tray or fluid-bed drying, dry screening, lubrication, and compression.
4. Spray Drying: Solution or slurry containing formula components is atomized into a heated drying chamber to yield spherical granules.

Tablet coating operations include sugar coating, enteric coating, and film coating:

• Sugar Coating: Performed in rotating coin-shaped pans via five sequential stages: (1) Waterproofing and sealing (using shellac/resins); (2) Subcoating (3 to 5 coats of syrup containing gelatin and gum); (3) Smoothing and final rounding; (4) Finishing and coloring; (5) Polishing (using carnauba or beeswax).
• Enteric Coating: Resists gastric fluid dissolution to protect acid-labile drugs or minimize gastric irritation. Polymers include cellulose acetate phthalate (CAP), coated in combination with butyl stearate, carnauba wax, and stearic acid melted at $75^\circ\text{C}$.
• Film Coating: Polymer film sprayed directly onto tablets. Solutions contain film formers (CAP, hydroxypropyl methylcellulose), water-permeability modifiers (polyethylene glycol), plasticizers (castor oil), surfactants (polyoxyethylene sorbitan derivatives), opaquant-colorants (titanium dioxide), and volatile organic solvents.

Tablet Evaluation and Processing Defect Analysis

During tablet compression, operational variables cause physical defects that require specific corrective actions:

• Capping: Partial or complete separation of the top or bottom crown of the tablet from the main body.

• Lamination: Separation of the tablet into two or more distinct parallel layers. Capping and lamination are caused by air entrapment within light, fluffy granulations or excessive fine particles. Corrective steps include adding binders, changing solvent systems, or screening out excessive fines.

• Chipping: Breaking of tablet edges during handling.

• Picking: Material adhering to punch faces, lifting surface details off the tablet.

• Sticking: Granulation adhering to die walls, causing side scratch marks and machine noise. Corrected by increasing lubrication or reducing moisture.

• Mottling: Unequal, non-uniform distribution of color on the tablet surface. Caused by drug-excipient color contrast or dye migration during wet granulation drying. Corrected by using insoluble lake dyes, altering solvent systems, reducing drying temperatures, or reducing particle size.

• Weight Variation: Caused by inconsistent die filling due to poor powder flowability, improper mixing of lubricants/glidants, or wide particle size distribution.

• Hardness Variation: Caused by inconsistent die fill volumes or variable spatial clearance between upper and lower punches at peak compression.

• Double Impression: Occurs when lower punches featuring embossed monograms rotate slightly during ejection, striking the tablet bottom face a second time.

• Evaluation Tests: Completed compressed tablets undergo physical and chemical testing:

  1. Hardness Testing: Measures radial breaking force. Equipment includes Strong-Cobb (calibrated to $30\text{ lbs/in}^2$ or kg equivalent), Stokes-Monsanto (threaded spring plunger mechanism), Eureka (motorized sliding weight beam balance), and Pfizer (hand-held plier mechanism).
  2. Dissolution Testing: Quantifies drug release rate over time in $0.1\text{ N HCl}$, water, or buffer media maintained at $37^\circ\text{C}$.
  3. Friability Testing: Evaluates mechanical durability against abrasion using a Roche Friabilator. Test tablets rotate through a $6\text{ inch}$ drop height inside a drum; a weight loss of less than $0.8\text{\%}$ is acceptable.
  4. Disintegration Testing: Measures time required for tablets to break down into soft masses without firm cores in aqueous media at $37^\circ\text{C}$. Required disintegration times range from $5\text{ minutes}$ to $30\text{ minutes}$.
  5. Weight Variation Tolerances: Evaluated on $20\text{ individual units}$. USP criteria permit no more than 2 tablets to deviate beyond specified limits, with zero tablets exceeding double the percentage allowance:
  • Tablet average weight $≤ 130\text{ mg}$: Percentage allowance = $10\text{\%}$
  • Tablet average weight $130\text{ mg}$ to $324\text{ mg}$: Percentage allowance = $7.5\text{\%}$
  • Tablet average weight $324\text{ mg}$ and over: Percentage allowance = $5\text{\%}$
  1. Tablet Thickness: Measured with micrometer calipers at compression startup and routine intervals.
  2. Content Uniformity: Assayed on 10 individual units to confirm drug distribution homogeneity. Meets USP standards if 9 of 10 tablets fall within $85\text{\%}$ to $115\text{\%}$ of stated potency, and no single unit falls outside $75\text{\%}$ to $125\text{\%}$.

Hard and Soft Gelatin Capsules: Principles, Production, and Quality Control

Capsules are solid dosage forms in which active ingredients and excipients are enclosed within a gelatin shell. Inverted by Mothes and Dublanc, gelatin capsules offer high visual elegance, taste masking, and ease of swallowing. Highly soluble salts (KCl, KBr, $NH_4Cl$) are excluded due to localized GI mucosal irritation upon rapid dissolution. Efflorescent materials soften gelatin shells by releasing water, whereas deliquescent materials dry out shells by absorbing water from the gelatin.

Hard gelatin capsules consist of two telescoping body and cap pieces. Shells are manufactured from gelatin, water, colorants, and opacifying agents ($TiO_2$). Gelatin formulations combine bone gelatin (imparts toughness and structural firmness) and pork skin gelatin (imparts clarity and plasticity). Moisture content is maintained between $12\text{\%}$ and $16\text{\%}$. Storage above $100^\circ\text{F}$ ($37.8^\circ\text{C}$) or high humidity causes softening and tackiness; low humidity causes brittleness and dimensional distortion.

Standard hard capsule sizes for human use range from Size 0 (largest standard size) to Size 5 (smallest standard size), alongside larger veterinary sizes. Powder fills require glidants/lubricants (silicon dioxide, metallic stearates, talc, glycol esters) and diluents (lactose, mannitol, starch, bentonite). Quality tests include:

• Weight Variation: Individual weights of 20 intact capsules are averaged. The batch passes if no capsule falls outside $90\text{\%}$ to $110\text{\%}$ of the average weight.
• Content Uniformity: Assayed across 30 units (10 initially). Met if 9 of 10 are within $85\text{\%}$ to $115\text{\%}$, and the 10th does not exceed $75\text{\%}$ to $125\text{\%}$.
• Finishing and Polishing: Dusting and polishing are accomplished via pan polishing (Accela-Cota pan lined with polyurethane/cheesecloth), cloth dusting (manual rubbing with oiled cloths), or rotary soft brush vacuum equipment.
• Special Modifications: Incompatible drugs are separated using a two-phase fill (placing a small soft capsule, pill, or film-coated tablet inside before adding powder fill). Capsule shells are imprinted using offset printing presses.

Soft gelatin capsules contain a single, hermetically sealed shell rendered elastic by adding plasticizers such as glycerin USP, sorbitol USP, or Sorbitol Special. Shell properties are defined by:

• Bloom Gel Strength: Measures cohesive cross-linking strength. Quantified as the weight in grams required to depress a $0.5\text{ inch}$ plastic plunger a depth of $4\text{ mm}$ into a $6\frac{2}{3}\text{\%}$ gelatin gel aged at $10^\circ\text{C}$ for $17\text{ hours}$.
• Viscosity: Determined on a $6\frac{2}{3}\text{\%}$ aqueous gel at $60^\circ\text{C}$, dictating film casting parameters.

Soft gel contents comprise liquids, solution mixtures, or suspensions of solid drugs (milled to $≥ 80\text{ mesh}$) in non-aqueous vehicles. Volatile or water-miscible liquids (water, ethanol, emulsions) and primary plasticizers (glycerin, propylene glycol) cannot be encapsulated as major contents due to shell dissolution or migration.

Manufacturing processes for soft gels include:

• Plate Process: Batch method where a lower gelatin sheet is laid over a die mold, liquid medication is poured, an upper gelatin sheet is placed, and hydraulic pressure seals and cuts the capsules.
• Rotary Die Process: Continuous method where continuous ribbons of liquid gelatin pass over counter-rotating die rolls. A positive displacement metering pump injects liquid drug formulation into gelatin pockets simultaneously with heat ($37^\circ\text{C}$ to $40^\circ\text{C}$) and pressure sealing.

Gelatin raw mass is prepared in Pony Mixers at $57^\circ\text{C}$ to $60^\circ\text{C}$. Liquid vehicles and solids are blended in jacketed stainless steel tanks ($10\text{ to }450\text{ gallons}$) using Cowles mixers, milled through homogenizers, and deaerated under vacuum. Following encapsulation, soft gels are washed in a naphtha solvent unit to remove mineral oil lubricants, passed through an infrared dryer (removing $60\text{\%}$ to $70\text{\%}$ of shell water), spread on drying trays at $20\text{\%}$ to $30\text{\%}$ relative humidity ($21^\circ\text{C}$ to $24^\circ\text{C}$), and processed through automatic diameter sorters (tolerance $∓0.020\text{ inches}$) and photoelectric color sorters prior to packaging.